Northern Trust Corp Buys 15,843 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT)

Northern Trust Corp lifted its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT - Free Report) by 5.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 327,815 shares of the medical instruments supplier's stock after purchasing an additional 15,843 shares during the period. Northern Trust Corp owned about 1.46% of LeMaitre Vascular worth $30,205,000 as of its most recent filing with the SEC.

A number of other hedge funds have also bought and sold shares of the company. New York State Teachers Retirement System grew its position in shares of LeMaitre Vascular by 1.2% during the 4th quarter. New York State Teachers Retirement System now owns 8,189 shares of the medical instruments supplier's stock valued at $755,000 after buying an additional 100 shares during the last quarter. Flputnam Investment Management Co. grew its holdings in shares of LeMaitre Vascular by 3.6% during the fourth quarter. Flputnam Investment Management Co. now owns 2,923 shares of the medical instruments supplier's stock valued at $269,000 after purchasing an additional 102 shares during the last quarter. Norden Group LLC raised its position in shares of LeMaitre Vascular by 4.5% during the 4th quarter. Norden Group LLC now owns 2,371 shares of the medical instruments supplier's stock worth $218,000 after purchasing an additional 103 shares during the period. Blue Barn Wealth LLC grew its stake in LeMaitre Vascular by 4.4% during the 4th quarter. Blue Barn Wealth LLC now owns 2,485 shares of the medical instruments supplier's stock worth $229,000 after buying an additional 104 shares during the last quarter. Finally, Shaker Investments LLC OH lifted its stake in LeMaitre Vascular by 0.8% in the fourth quarter. Shaker Investments LLC OH now owns 13,948 shares of the medical instruments supplier's stock valued at $1,285,000 after buying an additional 112 shares during the last quarter. 84.64% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

Several research analysts have recently issued reports on the company. Oppenheimer cut LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Lake Street Capital boosted their price target on shares of LeMaitre Vascular from $105.00 to $110.00 and gave the stock a "buy" rating in a research report on Friday, February 28th. Barrington Research lowered shares of LeMaitre Vascular from an "outperform" rating to a "market perform" rating in a research note on Friday, February 28th. Finally, Wells Fargo & Company initiated coverage on shares of LeMaitre Vascular in a report on Thursday, February 13th. They issued an "equal weight" rating and a $95.00 price objective for the company. Five research analysts have rated the stock with a hold rating, three have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, LeMaitre Vascular has a consensus rating of "Moderate Buy" and an average price target of $98.14.

Insider Activity

In other LeMaitre Vascular news, insider Trent G. Kamke sold 2,009 shares of the business's stock in a transaction dated Wednesday, March 12th. The shares were sold at an average price of $82.12, for a total value of $164,979.08. Following the transaction, the insider now directly owns 5,564 shares in the company, valued at $456,915.68. The trade was a 26.53% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 10.79% of the stock is owned by company insiders.

LeMaitre Vascular Stock Up 0.8%

NASDAQ LMAT traded up $0.64 during midday trading on Friday, hitting $83.94. The company had a trading volume of 23,784 shares, compared to its average volume of 163,473. The stock has a market cap of $1.90 billion, a price-to-earnings ratio of 45.81, a P/E/G ratio of 2.22 and a beta of 0.86. The firm has a fifty day simple moving average of $84.14 and a two-hundred day simple moving average of $92.95. LeMaitre Vascular, Inc. has a fifty-two week low of $71.42 and a fifty-two week high of $109.58.

LeMaitre Vascular (NASDAQ:LMAT - Get Free Report) last posted its quarterly earnings results on Thursday, May 1st. The medical instruments supplier reported $0.48 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.50 by ($0.02). The company had revenue of $59.87 million during the quarter, compared to analyst estimates of $57.61 million. LeMaitre Vascular had a return on equity of 13.15% and a net margin of 19.40%. The business's revenue for the quarter was up 12.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $0.44 earnings per share. As a group, equities analysts predict that LeMaitre Vascular, Inc. will post 1.94 earnings per share for the current year.

LeMaitre Vascular Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Thursday, May 29th. Stockholders of record on Thursday, May 15th will be given a dividend of $0.20 per share. The ex-dividend date is Thursday, May 15th. This represents a $0.80 annualized dividend and a dividend yield of 0.95%. LeMaitre Vascular's dividend payout ratio (DPR) is currently 40.40%.

LeMaitre Vascular Company Profile

LeMaitre Vascular, Inc develops, manufactures, and markets medical devices and implants used in the field of vascular surgery worldwide. It offers human cadaver tissue cryopreservation services; angioscope, a fiberoptic catheter used for viewing the lumen of a blood vessel; embolectomy catheters to remove blood clots from arteries; thrombectomy catheters for removing thrombi in the venous system; occlusion catheters that temporarily occlude the blood flow; and perfusion catheters to perfuse the blood and other fluids into the vasculature.